CASI PHARMACEUTICALS, INC. Deferred Tax Assets, Goodwill and Intangible Assets
CASI PHARMACEUTICALS, INC. (CASIF) had Deferred Tax Assets, Goodwill and Intangible Assets of $5.43 million as of 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2026-05-15
- 2025-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $5.43M.
- 2024-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $6.20M.
- 2023-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $6.61M.
- 2022-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $9.49M.
| Period end | Deferred Tax Assets, Goodwill and Intangible Assets |
|---|---|
| 2025-12-31 | $5.43M 20-F · filed 2026-05-15 |
| 2024-12-31 | $6.20M 20-F · filed 2026-05-15 |
| 2023-12-31 | $6.61M 20-F · filed 2025-03-31 |
| 2022-12-31 | $9.49M 20-F · filed 2024-03-28 |
| 2021-12-31 | $8.05M 20-F · filed 2023-04-26 |